Product Images Pioglitazone And Metformin

View Photos of Packaging, Labels & Appearance

Product Label Images

The following 3 images provide visual information about the product associated with Pioglitazone And Metformin NDC 70882-105 by Cambridge Therapeutics Technologies, Llc, such as packaging, labeling, and the appearance of the drug itself. This resource could be helpful for medical professionals, pharmacists, and patients seeking to verify medication information and ensure they have the correct product.

Pioglitazone - pioglitazone and metformin hcl tablets sandoz 1

Pioglitazone - pioglitazone and metformin hcl tablets   sandoz 1

The given text seems to be incomplete as it contains some symbols and only a part of a drug name "pioglitazone hydrochloride". Hence, a useful description cannot be generated from this text.*

Metform - pioglitazone and metformin hcl tablets sandoz 2

Metform - pioglitazone and metformin hcl tablets   sandoz 2

This is a label for metformin hydrochloride, a medication commonly used to treat type 2 diabetes.*

Pioglitazone and Metformin Tablets, USP 15mg/500mg - pioglitazone and metformin hcl tablets sandoz 3

Pioglitazone and Metformin Tablets, USP 15mg/500mg - pioglitazone and metformin hcl tablets   sandoz 3

This text is a proofread approval document for Keystone Folding Box Co. It contains terms and conditions confirming authorization of release to production under agreed conditions. There is also a warning about keeping drugs out of reach of children and a manufacturing statement for Cambridge Therapeutic Technologies. The text includes dosage information and a phone number for product inquiries. There is no clear context or purpose for the other text fragments in the document.*

* The product label images have been analyzed using a combination of traditional computing and machine learning techniques. It should be noted that the descriptions provided may not be entirely accurate as they are experimental in nature. Use the information in this page at your own discretion and risk.